July 18, 2025

Blood Test Predicts Organ Aging and Mortality

Researchers used blood proteins to estimate the biological age of 11 organs in over 44,000 people, revealing that older brain and immune systems were linked to higher disease and death risks, while younger ones predicted longer life.

Conexiant

July 17, 2025

Vapes Outperform Nicotine Replacement Therapy in Cessation Trial

Researchers found vaporized nicotine products more effective than nicotine replacement therapy for smoking cessation among socioeconomically disadvantaged adults.

Conexiant

July 17, 2025

Nirsevimab Shows 83% Efficacy Over 6 Months

A large clinical trial in Europe showed that a single dose of nirsevimab reduced infant hospitalizations for RSV-associated lower respiratory tract infections by over 80% over a six-month period.

Conexiant

July 17, 2025

Cancer History Linked to Severe COVID-19, Study 

Adult childhood cancer survivors had a higher risk of severe COVID-19 despite lower infection rates and higher vaccination coverage.

Conexiant

July 14, 2025

GLP-1 Use Tied to Reflux Complications

Researchers found that GLP-1 receptor agonists were associated with an increased risk of GERD and related complications in patients with type 2 diabetes.

Conexiant

July 10, 2025

HHS Scraps Preventive Care Panel Meeting

HHS unexpectedly canceled a meeting of the U.S. Preventive Services Task Force, prompting fears it may be dismantled following similar moves by Secretary Robert F. Kennedy Jr. at other federal health agencies.

Conexiant

July 09, 2025

Recombinant Zoster Vaccine Linked to New-Onset Lupus

Researchers report the first documented case of systemic lupus erythematosus following Shingrix vaccination.

Conexiant

July 08, 2025

Next-Gen Flu Vaccines Show Global Value

Researchers project that next-generation influenza vaccines could prevent up to 3 billion infections and be cost-effective in many countries with appropriate pricing strategies.

Conexiant

July 02, 2025

FDA Approves Ready-to-Infuse Vancomycin

Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis.

Conexiant